The World Health Organization identifies tuberculosis (TB), caused by Mycobacterium
tuberculosis, as a leading infectious killer. Although conventional treatments for TB exist …

Tuberculosis (TB) is a major global health problem and the second most prevalent infectious
killer after COVID-19. It is caused by Mycobacterium tuberculosis (Mtb) and has become …

Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to pose a significant
threat to global health. The resilience of TB is amplified by a myriad of physical, biological …

A developing use of nanotechnology in medicine involves using nanoparticles to administer
drugs, genes, biologicals, or other materials to targeted cell types, such as cancer cells. In …

Paediatric Tuberculosis (TB) continues to be a major global cause of morbidity and mortality.
Children are more prone to contracting TB, which can spread quickly to extrapulmonary …

Tuberculosis (TB) stands as an enduring and formidable global health challenge,
necessitating innovative methodologies to optimize therapeutic outcomes. Within this …

Tuberculosis (TB) is among the top 10 infectious diseases worldwide. It is categorized
among the leading killer diseases that are the reason for the death of millions of people …

Tuberculosis (TB) is a progressive, chronic, transmittable disease caused by the bacterium
Mycobacterium tuberculosis (Mtb), which has emerged as a major global infectious and …

The World Health Organization's (WHO) End TB strategy aims to eradicate the global TB
epidemic by 2035 through improved case detection, drug susceptibility testing, and rapid …

In the current scenario, the rise of multidrug-resistant strains of Mycobacterium tuberculosis
(MTB) poses a worldwide challenge. MTB is an acid-fast bacillus that shows varying …